Introduction
Methods
Results
Search Results
Author | Country | Year | Patient identification and selection for evaluation at the FLS | Selected patients, n
| Attenders, n (%) | Selection for publicationa
| Subjects, n (%)b
| Subjects, %c
| ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
IP/OP | F/M | Age | Fracture | Additional criteria | ||||||||
Patient selection for FLS evaluation conform recommendations, all FLS attenders selected for publication (n = 12) | ||||||||||||
McLellan [13] | GBR | 2003 | IP+OP | F+M | 50+ | All | 1 | 4671 | ||||
Blonk [19] | NLD | 2007 | IP+OP | F+M | 50+ | All | 1, 2, 5 | 1,220 | 1058 (87) | 1,058 (100) | 87 | |
Eekman [20] | NLD | 2014 | IP+OP | F+M | 50+ | All | 1, 9 | 2,207 | 1116 (51) | 1,116 (100) | 51 | |
Fraser [21] | AUS | 2016 | IP+OP | F+M | 50+ | All | 1 | 841 | 166 (20) | 166 (100) | 20 | |
Malgo [22] | NLD | 2016 | IP+OP | F+M | 50+ | All | 2, 3, 5, 6, 7 | 856 | 709 (83) | 709 (100) | 83 | |
Naranjo [23] | ESP | 2014 | IP+OP | F+M | 50+ | All | 1, 2, 6 | 532 | 330 (62) | 330 (100) | 62 | |
Naranjo [24] | ESP | 2015 | IP+OP | F+M | 50+ | All | 1, 2, 6 | 1324 | 759 (57) | 759 (100) | 57 | |
Ojeda [25] | ESP | 2010 | IP+OP | F+M | 50+ | All | 1, 2, 6 | 683 | 380 (56) | 380 (100) | 56 | |
Woltman [26] | NLD | 2010 | IP+OP | F+M | 50+ | All | 1,2 | 523 | 523 (100) | |||
Ong [27] | GBR | 2014 | IP+OP | F+M | 50+ | All | 1 | 4288 | 4,288 (100) | |||
Van den Berg [28] | NLD | 2014 | IP+OP | F+M | 50+ | All | 8 | 1898 | 1,898 (100) | |||
Huntjens [29] | NLD | 2011 | IP+OP | F+M | 50+ | All | 1, 2, 5 | 7199 | 7,199 (100) | |||
Patient selection for FLS evaluation conform recommendations, subgroup of FLS attenders selected for publication (n = 12) | ||||||||||||
Bours [30] | NLD | 2011 | IP+OP | F+M | 50+ | All | 1, 2, 3 | 893 | 656 (73) | a | 626 (95) | 70 |
De Klerk [31] | NLD | 2012 | IP+OP | F+M | 50+ | All | 1, 2, 5 | 194 | a | 176 (91) | ||
De Klerk [32] | NLD | 2013 | IP+OP | F+M | 50+ | All | 541 | a | 499 (92) | |||
Hegeman [33] | NLD | 2004 | IP+OP | F+M | 50+ | All | 1, 5 | 156 | 116 (74) | a | 100 (86) | 64 |
Wyers [34] | NLD | 2014 | IP+OP | F+M | 50+ | All | 1, 2, 3 | 3057 | 1694 (55) | a | 1,359 (80) | 44 |
Van Helden [35] | NLD | 2008 | IP+OP | F+M | 50+ | All | 2, 8, 9 | 797 | 708 (89) | a | 568 (80) | 71 |
Van Helden [36] | NLD | 2007 | IP+OP | F+M | 50+ | All | 2, 5, 8, 9 | 425 | 288 (68) | a, b | 277 (96) | 65 |
Langridge [37] | GBR | 2007 | IP+OP | F+M | 50+ | All | 1 | c | 2,489 | |||
Dumitrescu [38] | NLD | 2008 | IP+OP | F+M | 50+ | All | 2, 8 | 1013 | 590 (58) | a, d | 100 (17) | 10 |
Gallacher [39] | GBR | 2007 | IP+OP | F+M | 50+ | All | 1 | a, e | 337 | |||
Howat [40] | GBR | 2007 | IP+OP | F+M | 50+ | All | 1 | e | 577 | |||
Gallacher [41] | GBR | 2005 | IP+OP | F+M | 50+ | All | 1 | d, e | 50 | |||
Patient selection not conform recommendations (n = 9) | ||||||||||||
Huntjens [42] | NLD | 2013 | IP+OP | F+M | 50+ | NVF | 2, 9 | 834 | 834 (100) | |||
Ahmed [43] | IRL | 2012 | IP+OP | F+M | 45+ | All | 1 | 158 | 124 (78) | 124 (100) | 78 | |
Abbad [44] | FRA | 2016 | IP+OP | F+M | 75+ | All | 1 | 176 | 110 (64) | 110 (100) | 64 | |
Premaor [45] | GBR | 2010 | IP+OP | F | PM | All | 1 | 1641 | 1,641 (100) | |||
Premaor [46] | GBR | 2010 | IP+OP | F | PM | All | 1 | 1641 | f | 1,005 (61) | ||
Dehamchia [47] | FRA | 2014 | IP | F+M | No limit | All | 1, 5, 8, 9 | 872 | 338 (39) | g | 335 (99) | 38 |
Nassar [48] | FRA | 2014 | IP | F+M | 50+ | NVF | 1, 2, 5 | 528 | a | 362 (69) | ||
Ganda [49] | AUS | 2015 | NR | F+M | 45+ | All | 1, 2, 4, 10 | 828 | 560 (68) | b | 234 (42) | 28 |
Beringer [50] | GBR | 2006 | NR | F+M | No limit | All | 1 | a, h | 86 |
Patient Selection Procedure
Identification and Selection of Patients for Evaluation at the FLS
Attendance
FLS Attenders Included in the Publication
Components of the Phenotype
Age and Gender
Author | Age (mean) | Men (%) | Fracture location (%) | BMI (mean) | ||
---|---|---|---|---|---|---|
Hip | Clinical VF | NV/NH | ||||
IP+OP, F+M, 50+, all Fx | ||||||
McLellan [13] | ||||||
Blonk [19] | 64 | 24 | 9 | 5 | 86 | 27 |
Eekman [20] | 68 | 22 | ||||
Fraser [21] | 70 | 14 | 8 | 10 | 82 | |
Malgo [22] | 67 | 27 | 9 | 6 | 85 | |
Naranjo [23] | 71 | 23 | 22 | 6 | 72 | |
Naranjo [24] | 72 | 22 | 26 | |||
Ojeda [25] | 70 | 13 | 19 | 8 | 73 | 29 |
Woltman [26] | 73 | 21 | 23 | 2 | 75 | |
Ong [27] | 66 | 17 | ||||
Van den Berg [28] | 20 | |||||
Huntjens [29] | 67 | 23 | 6 | |||
Bours [30] | 23 | |||||
De Klerk [31] | 67 | 21 | 8 | 13 | 79 | 28 |
De Klerk [32] | 66 | 22 | ||||
Hegeman [33] | 67 | 26 | 11 | 3 | 86 | 25 |
Wyers [34] | 65 | 28 | 8 | 26 | ||
Van Helden [35] | 67 | 28 | 13 | 3 | 84 | |
Range | 64–73 | 13–28 | 6–26 | 2–13 | 72–86 | 25–29 |
IP+OP, F+M, 50+, NVF | ||||||
Gallacher [39] | 23 | 5 | Excl. | 95 | 24 | |
Howat [40] | 21 | 13 | Excl. | 87 | ||
Huntjens [42] | 67 | 27 | Excl. | |||
Range | 67 | 21–27 | 5–13 | Excl. | 87–95 | 24 |
IP+OP, F+M, all Fx, various ages | ||||||
Langridge [37] | 78 | 28 | ||||
Ahmed [43] | 19 | 2 | 3 | 95 | ||
Abbad [44] | 80 | 21 | 45 | |||
Miscellaneous | ||||||
Van Helden [36] | 67 | 28 | ||||
Dumitrescu [38] | 68 | 27 | 17 | 4 | 79 | |
Gallacher [41] | 66 | 24 | 26 | Excl. | 74 | |
Premaor [45] | Excl. | 6 | <1 | 94 | 27 | |
Premaor [46] | Excl. | 10 | <1 | 90 | 27 | |
Dehamchia [47] | 67 | 25 | 28 | |||
Nassar [48] | 74 | 13 | 51 | Excl. | 49 | 24 |
Ganda [49] | 65 | 20 | ||||
Beringer [50] | 65 | 30 | Excl. | 41 | 59 | |
Range overall | 64–80 | 13–30 | 2–51 | <1–41 | 49–95 | 24–29 |
Fracture Location
Body Mass Index
Bone Mineral Density
Vertebral Fracture Assessment
Trabecular Bone Score
Laboratory Tests
Author | DXA | Normal BMD (%) | Osteopenia (%) | Osteoporosis (%) | VFA | Any VF (%) | Grade 2/3 VF (%) | Lab | SECOB (%) | Vit. D def. (%) | Fall risk assessment | Fall risk (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
IP+OP, F+M, 50+, all Fx | ||||||||||||
Blonk [19] | + | 37 | + | + | – | |||||||
Van den Berg [28] | + | 12 | + | + | – | |||||||
Hegeman [33] | + | 23 | 44 | 33 | + | 22 | + | 69 | – | |||
De Klerk [31] | + | 35 | 38 | 27 | + | 42 | – | – | ||||
Huntjens [29] | + | 21 | 47 | 32 | – | + | + | |||||
McLellan [13] | + | – | + | – | ||||||||
Eekman [20] | + | – | + | – | ||||||||
Fraser [21] | + | 19 | 45 | 36 | – | + | – | |||||
Malgo [22] | + | 17 | 55 | 28 | – | + | 28 | 43 | – | |||
Naranjo [23] | + | 20 | 38 | 43 | – | + | – | |||||
Naranjo [24] | + | 13 | 44 | 42 | – | + | – | |||||
Ojeda [25] | + | – | + | – | ||||||||
Bours [30] | + | 15 | 46 | 30 | – | + | 27a, 70b
| 64 | – | |||
De Klerk [32] | + | 30 | 49 | 21 | – | + | 3/11c
| – | ||||
Wyers [34] | + | 23 | 48 | 30 | – | + | – | |||||
Van Helden [35] | + | 21 | 44 | 35 | – | – | + | 75 | ||||
Woltman [26] | + | 46 | – | – | – | |||||||
Ong [27] | + | – | – | – | ||||||||
Range | 13–35 | 38–55 | 12–46 | 22–42 | 3–70 | 43–69 | 75–80 | |||||
IP+OP, F+M, 50+, NVF | ||||||||||||
Gallacher [39] | + | 35 | 37 | 28 | + | 25 | 17 | + | – | |||
Howat [40] | + | + | 20 | – | + | |||||||
Huntjens [42] | + | – | – | + | 60 | |||||||
Range | 35 | 37 | 28 | 20–25 | 17 | 60 | ||||||
IP+OP, F+M, all Fx, various ages | ||||||||||||
Abbad [44] | + | 17 | 29 | 54 | + | 40 | – | + | ||||
Langridge [37] | + | – | + | + | ||||||||
Ahmed [43] | + | 33 | 38 | 29 | – | + | 64 | – | ||||
Miscellaneous | ||||||||||||
Dumitrescu [38] | + | Excl. | Excl. | + | 57 | 31 | + | 50b
| 62 | + | 79 | |
Nassar [48] | + | 52 | + | 37 | 21 | – | – | |||||
Gallacher [41] | + | Excl. | Excl. | – | + | 72 | – | |||||
Dehamchia [47] | + | 19 | 45 | 36 | – | + | – | |||||
Beringer [50] | + | – | + | 56 | – | |||||||
Van Helden [36] | + | 24 | 47 | 29 | – | – | + | 84 | ||||
Premaor [45] | + | 39 | 41 | 19 | – | – | – | |||||
Premaor [46] | + | 39 | 41 | 19 | – | – | – | |||||
Ganda [49] | + | – | – | – | ||||||||
Range overall | 13–39 | 29–55 | 12–54 | 20–57 | 17–31 | 3–70 | 43–72 | 60–84 |